Filing Details
- Accession Number:
- 0001209191-11-041982
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-02 13:00:00
- Reporting Period:
- 2011-08-01
- Filing Date:
- 2011-08-02
- Accepted Time:
- 2011-08-02 16:18:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1405288 | A Jacqualyn Fouse | C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-01 | 2,000 | $59.47 | 5,085 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2011-08-01 | 11,250 | $0.00 | 11,250 | $58.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,250 | 2021-08-01 | No | 4 | A | Direct |
Footnotes
- Option is immediately exercisable and will vest in four equal annual installments commencing on August 1, 2012.
- The option was issued pursuant to the Company's 2008 Stock Incentive Plan.